Newborn screening software

Wednesday, 14 September, 2005 | Supplied by: http://www.detente.com.au/


QuadraMed has completed implementation of a newborn screening laboratory information application for use with the company's Affinity Laboratory system by Great Ormond Street Hospital (GOSH) in London, UK.

The software features specialised functionality enabling the Newborn Screening Service to ensure the early detection and subsequent treatment of a number of newborn metabolic diseases to prevent potentially severe mental and/or physical disabilities. QuadraMed developed, installed, configured and fully implemented the first stage of this product in 10 weeks. Stage two enhancements will be provided over the next few months.

Newborn screening encompasses critical procedures conducted by selected centres in the UK. The staff at GOSH faced the sunset of their existing screening laboratory software and the increasing complexity of screening, thereby the need to enhance the hospital's ability to provide dependable data in the most timely manner.

Affinity Laboratory is a complete laboratory information system capable of providing consistent, accurate and timely data on a cost-effective basis. It is a fully scalable, comprehensive solution from specimen collection through cumulative result reporting. Included is a rules engine that differentiates patient recall letters based on a comprehensive range of critical criteria.

QuadraMed Affinity Laboratory is an integral part of the Affinity HIS (Healthcare Information System) suite of products.

Related Products

Yokogawa CellVoyager CV8000 high-content screening system

The high-end, high-content analysis system features a cell incubator with an airtight design that...

MBF Bioscience MicroDynamix spine analysis software

MicroDynamix by MBF Bioscience enables visualisation and quantification changes in spine...

Merck AIDDISON drug discovery software

The software identifies compounds from over 60 billion possibilities that have key properties of...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd